Abstract
In this series we draw attention to medicines that have entered the European market with an entirely new mechanism of action. Publication is not to be confused with endorsement of use in clinical practice. Copyright to the images belongs to Leiden University, but use of the images.
Cite
CITATION STYLE
APA
Rissmann, R., Hessel, M. H. M., & Cohen, A. F. (2015). Vemurafenib/dabrafenib and trametinib. British Journal of Clinical Pharmacology, 80(4), 765–767. https://doi.org/10.1111/bcp.12651
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free